Angelo B A Laranjeira

Comprehensive profiling of clinical JAK inhibitors in myeloproliferative neoplasms.

S. Oh, Daniel A. C. Fisher, Maggie J. Allen, 2022, American journal of hematology.

Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms

S. Sykes, J. Di Paola, K. Ashworth, 2023, bioRxiv.